Elixir Medical’s DynamX Bioadaptor Outperforms Drug-Eluting Stent in Acute Coronary Syndrome Patients

Elixir Medical, known for its innovative technologies in treating cardiovascular disease, has announced compelling late-breaking data showcasing the advantages of the DynamX® Coronary Bioadaptor System over the Resolute Onyx™ zotarolimus drug-eluting stent (DES) in reducing target lesion failure (TLF) among…

Read MoreElixir Medical’s DynamX Bioadaptor Outperforms Drug-Eluting Stent in Acute Coronary Syndrome Patients

Egnite Inc. Shows Survival Boost for Asymptomatic Aortic Stenosis Patients Post-AVR

Egnite, Inc., a leading cardiovascular digital health company, has announced significant findings from its research on the real-world effects of clinical presentation in patients with moderate or greater aortic stenosis (AS) undergoing aortic valve replacement (AVR). Presented by Dr. Philippe…

Read MoreEgnite Inc. Shows Survival Boost for Asymptomatic Aortic Stenosis Patients Post-AVR

Cleerly Unveils AI-Enabled CT Research for Predicting Cardiovascular Events at TCT 2024

Late-breaking results from the CONFIRM2 global multicenter study were presented today at the Transcatheter Cardiovascular Therapeutics (TCT) 2024 conference. The study highlighted how a non-invasive, comprehensive AI-based analysis of cardiac computed tomography (CT) can effectively predict serious heart-related events in…

Read MoreCleerly Unveils AI-Enabled CT Research for Predicting Cardiovascular Events at TCT 2024

Healthcare Workforce Logistics Named Recommended Managed Service Provider in SIA Survey

Healthcare Workforce Logistics (HWL), a leader in healthcare workforce management solutions, has been recognized as a recommended Managed Service Program (MSP) provider in Staffing Industry Analysts’ (SIA) recent report on VMS and MSP fees. This recognition stems from responses in…

Read MoreHealthcare Workforce Logistics Named Recommended Managed Service Provider in SIA Survey

Cardiawave Reports Positive Six-Month Data from Valvosoft Study at TCT Conference

Cardiawave SA, the developer of the innovative Valvosoft Non-Invasive Ultrasound Therapy (NIUT) device for severe symptomatic calcific aortic stenosis (CAS), announced today that the device achieved its primary endpoint in a pivotal study. Six months post-treatment, 80.5% of patients experienced…

Read MoreCardiawave Reports Positive Six-Month Data from Valvosoft Study at TCT Conference

Exact Sciences Showcases Leadership in Noninvasive Colorectal Cancer Screening at ACG 2024

Exact Sciences Corp. (NASDAQ: EXAS), a leader in cancer screening and diagnostics, has announced that it will present modeling data assessing the benefits and burdens of established colorectal cancer (CRC) screening strategies, including the Cologuard Plus™ test, at the American…

Read MoreExact Sciences Showcases Leadership in Noninvasive Colorectal Cancer Screening at ACG 2024

Odyssey Therapeutics to Showcase Data on OD-07656 at ACG 2024

Odyssey Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on improving treatments for autoimmune and inflammatory diseases, announced that new translational data for its RIPK2 scaffolding inhibitor, OD-07656, will be presented at the American College of Gastroenterology (ACG) Annual Scientific Meeting…

Read MoreOdyssey Therapeutics to Showcase Data on OD-07656 at ACG 2024